science

"The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020": why contrarians say the sector is a purchase

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase

If you want to know how much investors hate the biotech industry right now, consider this simple statistic: More than 25% of small biotech companies have lower market capitalizations than they have in cash. “The market is saying that a quarter of these companies are literally worth nothing,” says Jefferies biotech analyst Michael Yee, who …

“The capitulation model for biotechnology is a category 5 storm, the same as energy in 2020”: why contrarians say the sector is a purchase Read More »

It's another bad week for biotech stocks.  Relief could come next month.

It’s another bad week for biotech stocks. Relief could come next month.

Text size About 80 biotechnologies in Russell 2000 have market capitalizations below last year’s inclusion limit. Time to dream The biotech acquisitions were supposed to revive the sector, but despite the biggest deal reached this year, this was yet another bad week, very bad for equities. The end may come soon, painfully but positively, according …

It’s another bad week for biotech stocks. Relief could come next month. Read More »

Mouser Named Senior Engineering Design Showcase Philanthropic Partner |  Deal

Mouser Named Senior Engineering Design Showcase Philanthropic Partner | Deal

DALLAS & FORT WORTH, Texas – (BUSINESS WIRE) – May 12, 2022– Mouser Electronics, Inc., the innovation-enhancing new product introduction (NPI) ™ leader, is delighted to be a philanthropic partner of the ExCellence in Senior Design (ESD) Showcase 2022, taking place on 19th and 20th May at the University of Texas at Dallas. Mouser Electronics …

Mouser Named Senior Engineering Design Showcase Philanthropic Partner | Deal Read More »

Mouser Named Senior Engineering Design Showcase Philanthropic Partner |  Deal

Mouser Named Senior Engineering Design Showcase Philanthropic Partner | Deal

DALLAS & FORT WORTH, Texas – (BUSINESS WIRE) – May 12, 2022– Mouser Electronics, Inc., the innovation-enhancing new product introduction (NPI) ™ leader, is delighted to be a philanthropic partner of the ExCellence in Senior Design (ESD) Showcase 2022, taking place on 19th and 20th May at the University of Texas at Dallas. This press …

Mouser Named Senior Engineering Design Showcase Philanthropic Partner | Deal Read More »

SIU's $ 13 million interdisciplinary food, fermentation and biotechnology research hub advances - AgriNews

SIU’s $ 13 million interdisciplinary food, fermentation and biotechnology research hub advances – AgriNews

CARBONDALE, Illinois – The Southern Illinois University Board of Trustees has approved deals that pave the way for a new multimillion-dollar interdisciplinary economic research and development center, capitalizing on SIU Carbondale’s research on food, fermentation and biotechnology. The Illinois Food, Entrepreneurship, Research and Manufacturing Hub will provide a cutting-edge research and training suite for faculty, …

SIU’s $ 13 million interdisciplinary food, fermentation and biotechnology research hub advances – AgriNews Read More »

Biotech stocks are having a terrible year.  These 10 are still winning.

Biotech stocks are having a terrible year. These 10 are still winning.

Even in the risky biotech sector, investors are looking for slightly less risk. Time to dream Text size It would be difficult to overstate the poor performance of biotech stocks this year. Even as investors rushed into defensive healthcare stocks, the SPDR S&P Biotech listed fund (ticker: XBI) fell 37% in 2022 at close of …

Biotech stocks are having a terrible year. These 10 are still winning. Read More »

Biotech stocks are having a terrible year.  These 10 are still winning.

Biotech stocks are having a terrible year. These 10 are still winning.

Text size Even in the risky biotech sector, investors are looking for slightly less risk. Time to dream It would be difficult to overstate the poor performance of biotech stocks this year. Even as investors rushed into defensive healthcare stocks, the SPDR S & P Biotech ETF (ticker: XBI) was down 37.3% in 2022 at …

Biotech stocks are having a terrible year. These 10 are still winning. Read More »

Biotech stocks are still in decline.  The near-term outlook is bleak.

Biotech stocks are still in decline. The near-term outlook is bleak.

Text size Barron’s said in late March that the long-term arguments for biotech stocks are strong. Time to dream For biotech stocks this year, April was indeed the cruelest month. The SPDR S&P Biotech listed fund (ticker: XBI) fell 17.9% in April, bringing the total decline for 2022 to 34.1%. Over the past 12 months, …

Biotech stocks are still in decline. The near-term outlook is bleak. Read More »

This biotech company sees DNA testing as a formula for growth

This biotech company sees DNA testing as a formula for growth

Oxford Nanopore Technologies manufactures Covid-19 technology to identify new variants and test and analyze DNA. Courtesy of Oxford Nanopore Technologies Text size Biotechnology company Oxford Nanopore Technologies , which went public on the London market eight months ago, produces Covid-19 technology to identify new variants, but its experience in DNA testing and data analysis is …

This biotech company sees DNA testing as a formula for growth Read More »

Google Finance Manager: Anything that can be automated, we strive to automate

Google Finance Manager: Anything that can be automated, we strive to automate

Alphabet Inc Google is working to automate as many financial tasks as possible as it seeks to reduce the amount of manual work its employees have to do. The Mountain View, California-based software giant uses a combination of tools including artificial intelligence, automation, cloud, data lake, and machine learning to run its financial operations and …

Google Finance Manager: Anything that can be automated, we strive to automate Read More »